Introduction: Vasopressin therapy.
Publication
, Journal Article
Whellan, DJ
Published in: Heart Fail Rev
June 2009
Duke Scholars
Published In
Heart Fail Rev
DOI
EISSN
1573-7322
Publication Date
June 2009
Volume
14
Issue
2
Start / End Page
57 / 58
Location
United States
Related Subject Headings
- Vasopressins
- Tolvaptan
- Sodium
- Hyponatremia
- Humans
- Heart Failure
- Chronic Disease
- Cardiovascular System & Hematology
- Benzazepines
- Antidiuretic Hormone Receptor Antagonists
Citation
APA
Chicago
ICMJE
MLA
NLM
Whellan, D. J. (2009). Introduction: Vasopressin therapy. Heart Fail Rev, 14(2), 57–58. https://doi.org/10.1007/s10741-008-9116-8
Whellan, David J. “Introduction: Vasopressin therapy.” Heart Fail Rev 14, no. 2 (June 2009): 57–58. https://doi.org/10.1007/s10741-008-9116-8.
Whellan DJ. Introduction: Vasopressin therapy. Heart Fail Rev. 2009 Jun;14(2):57–8.
Whellan, David J. “Introduction: Vasopressin therapy.” Heart Fail Rev, vol. 14, no. 2, June 2009, pp. 57–58. Pubmed, doi:10.1007/s10741-008-9116-8.
Whellan DJ. Introduction: Vasopressin therapy. Heart Fail Rev. 2009 Jun;14(2):57–58.
Published In
Heart Fail Rev
DOI
EISSN
1573-7322
Publication Date
June 2009
Volume
14
Issue
2
Start / End Page
57 / 58
Location
United States
Related Subject Headings
- Vasopressins
- Tolvaptan
- Sodium
- Hyponatremia
- Humans
- Heart Failure
- Chronic Disease
- Cardiovascular System & Hematology
- Benzazepines
- Antidiuretic Hormone Receptor Antagonists